Vaccitech PLC
F:2AB

Watchlist Manager
Vaccitech PLC Logo
Vaccitech PLC
F:2AB
Watchlist
Price: 0.585 EUR -1.68% Market Closed
Market Cap: 22.8m EUR

Wall Street
Price Targets

2AB Price Targets Summary
Vaccitech PLC

Wall Street analysts forecast 2AB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 2AB is 4.106 EUR with a low forecast of 2.439 EUR and a high forecast of 5.917 EUR.

Lowest
Price Target
2.439 EUR
317% Upside
Average
Price Target
4.106 EUR
602% Upside
Highest
Price Target
5.917 EUR
911% Upside
Vaccitech PLC Competitors:
Price Targets
ADAG
Adagene Inc
409% Upside
FDMT
4D Molecular Therapeutics Inc
328% Upside
002007
Hualan Biological Engineering Inc
26% Upside
002675
Yantai Dongcheng Biochemicals Co Ltd
33% Upside
2696
Shanghai Henlius Biotech Inc
67% Upside
300676
BGI Genomics Co Ltd
30% Upside
CRBU
Caribou Biosciences Inc
584% Upside

Revenue
Forecast

Revenue Estimate
Vaccitech PLC

For the last 4 years the compound annual growth rate for Vaccitech PLC's revenue is 33%.

33%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-20%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Vaccitech PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
Vaccitech PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 2AB's stock price target?
Price Target
4.106 EUR

According to Wall Street analysts, the average 1-year price target for 2AB is 4.106 EUR with a low forecast of 2.439 EUR and a high forecast of 5.917 EUR.

Back to Top